01 2Anonima Materie Sintetiche and Affini (AMSA) Spa
02 1Arch Pharmalabs Limited
03 1Aurobindo Pharma Limited
04 2Bidachem S.p.a.
05 1Cipla Ltd.
06 1Derivados Quimicos SAU
07 1Ipca Laboratories Limited
08 1Kalchem International inc
09 1LETCO MEDICAL, LLC
10 1Medisca Inc.
11 1Professional Compounding Centers of America dba PCCA
12 1Quimica Sintetica S.A.
13 1Shandong Xinhua Pharmaceutical Company Limited
14 1Spectrum Laboratory Products, Inc.
15 1Swati Spentose Private Limited
16 1Unichem Laboratories Limited, India
17 1Xenex Laboratories Inc
18 1Zydus Lifesciences Limited
27
PharmaCompass offers a list of Meloxicam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Meloxicam manufacturer or Meloxicam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Meloxicam manufacturer or Meloxicam supplier.
PharmaCompass also assists you with knowing the Meloxicam API Price utilized in the formulation of products. Meloxicam API Price is not always fixed or binding as the Meloxicam Price is obtained through a variety of data sources. The Meloxicam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, including repackagers and relabelers. The FDA regulates 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide supplier is an individual or a company that provides 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide active pharmaceutical ingredient (API) or 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide finished formulations upon request. The 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide suppliers may include 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide API manufacturers, exporters, distributors and traders.
click here to find a list of 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide suppliers with NDC on PharmaCompass.
We have 18 companies offering 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
Get in contact with the supplier of your choice:
